Non-Medical Switching

FDA Hearings Underscore Need for Clear Policy on Biosimilars

July 20, 2016

July 12 and 13 hearings of the FDA’s Arthritis Advisory Committee cleared the way for two new biosimilars, adalimumab and etanercept. The committee unanimously supported manufacturers’ applications for the drugs – but that wasn’t the only point of consensus. Participants and even committee members expressed concerns about unfinished regulatory policy and the need to prioritize patient safety.

IfPA Releases “Improving Access to Respiratory Care”

April 8, 2016

Patients with respiratory conditions are often not sick enough to be in critical care but not well enough to deal with their symptoms without consistent intervention. So explains a newly released white paper from the Institute for Patient Access and the Alliance for Patient Access’ Respiratory Therapy Access Working Group.

New AfPA Video Explains Non-Medical Switching

February 9, 2016

Patients with chronic or serious medical conditions must sometimes work with physicians for months to identify a medication that’s effective for them. But as a new video from the Alliance for Patient Access explains, patients may discover that this trial-and-error process was in vain.